Update on riboflavin and multiple sclerosis: a systematic review

Authors

  • Ahmad Saedisomeolia Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran|Department of Pharmacology, School of Medicine, Western Sydney University, NSW, Australia
  • Alireza Sarkaki Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Khuzestan, Iran
  • Mahshid Naghashpour Abadan School of Medical Sciences, Abadan, Iran|Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Khuzestan, Iran
  • Reza Amani Food Security Research Center, Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran|Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Khuzestan, Iran
  • Sima Jafarirad Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Khuzestan, Iran|Department of Nutrition, Faculty of Para-Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Khuzestan, Iran
Abstract:

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Riboflavin plays an important role in myelin formation, and its deficiency is implicated as a risk factor for multiple sclerosis. Here, we systematically reviewed the literature concerning the health benefits of riboflavin on MS. The literature recorded within four main databases, including relevant clinical trials, experimental, and case-control studies from 1976 to 2017 were considered. Both human and animal studies were included for review, with no restrictions on age, gender, or ethnicity.  Experimental studies demonstrated that riboflavin deficiency triggers neurologic abnormalities related to peripheral neuropathies such as demyelinating neuropathy. Moreover, randomized controlled trials (RCT) and case-control studies in which MS patients received riboflavin supplementation or had higher dietary riboflavin intake showed improvements in neurological motor disability. Riboflavin is a cofactor of xanthine oxidase and its deficiency exacerbates low uric acid caused by high copper levels, leading to myelin degeneration. The vitamin additionally plays a significant role in the normal functioning of glutathione reductase (GR) as an antioxidant enzyme, and conditions of riboflavin deficiency lead to oxidative damage. Riboflavin promotes the gene and protein levels of brain-derived neurotrophic factor (BDNF) in the CNS of an animal model of MS, suggesting that BDNF mediates the beneficial effect of riboflavin on neurological motor disability. Research to date generally supports the role of riboflavin in MS outcomes. However, further observational and interventional studies on human populations are warranted to validate the effects of riboflavin.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Effects of Meat Consumption on Multiple Sclerosis: A Systematic Review and Meta-analysis

Backgrounds and Objectives: Multiple sclerosis is a common cause of neurological disabilities worldwide. Diet is a potential risk factor for the pathogenesis of multiple sclerosis  and dietary intervention can be used as a prevention method for multiple sclerosis. The purpose of this study was the investigation of relationships between the type of meat consumed by the patients and multiple scle...

full text

O 9: Immunomodulatory Effects of Neural Stem Cell on Multiple Sclerosis: A Systematic Review

Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are chronic inflammatory demyelinating disorders of central nervous system (CNS). While the cause is unclear, the fundamental mechanism is thought to be destruction of myelin sheaths of neurons through immune system. One of the approaches being proposed in EAE therapy is neural stem cells (NSCs) trans...

full text

Depression and Anxiety in Patients with Multiple Sclerosis (MS): A Systematic Review (In press)

Background: Multiple Sclerosis (MS) is considered as one of the most prevalent chronic and progressive neurological diseases that has high simultaneity with some psychological disorders such as depression and anxiety; we examined depression and anxiety in people suffering from MS in this review study.  Methods: We conducted this study using a systematic review method relying on the search from...

full text

Effect of Progressive Muscle Relaxation on the outcomes of Multiple Sclerosis disease: A systematic review and meta-analysis

Introduction: Multiple sclerosis (MS) is an inflammatory disease, makes damage in central nervous system. Evidence showed Progressive Muscle Relaxation (PMR) technique is one of the non-pharmacological methods used to treat MS. The purpose of the study was to determining the effect of PMR on the MS's outcomes in published papers in the field.  Method: This systematic and meta-analysis study we...

full text

Association between Tumor Necrosis Factor- α-308 G/A Polymorphism and Multiple Sclerosis: A Systematic Review and Meta-Analysis

Multiple sclerosis (MS) is a complex polygenic disease in which gene-environment interactions are important. A number of studies have investigated the association between tumor necrosis factor-α (TNF-α) -308 G/A polymorphism (substitution G→A, designated as TNF1 and TNF2) and MS susceptibility in different populations, but the results of individual studies have been inconsistent. Therefore, per...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 20  issue 9

pages  958- 966

publication date 2017-09-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023